These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 7168636)
1. [Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients]. Ferlito S; La Spina E; Fichera C; Cultrera E; Patanè M; Ciulla P Arch Sci Med (Torino); 1982; 139(4):441-8. PubMed ID: 7168636 [No Abstract] [Full Text] [Related]
2. [Plafibride treatment of hyperlipidemias type II and IV]. Soler J; Vinzia C; Gómez JM; Morató J Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212 [No Abstract] [Full Text] [Related]
3. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial. Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129 [No Abstract] [Full Text] [Related]
4. [Lipid changes after fasting in obese patients]. Schrub JC; Joly JP; Wolf LM; Courtois H; Matray P; Rousseau PY; Brunelle P Sem Hop; 1973 Apr; 49(19):1349-56. PubMed ID: 4355381 [No Abstract] [Full Text] [Related]
5. [Blood lipid balance in simple diabetes mellitus or diabetes with excess weight, in relation to age and sex (epidemiological study)]. Mincu I; Câmpeanu S; Dumitrescu C; Mihalache N; Ionescu D Med Interna (Bucur); 1971 Dec; 23(12):1455-70. PubMed ID: 5159282 [No Abstract] [Full Text] [Related]
6. [Comparison of the plasmatic lipid pattern in obese diabetics before and after treatment with insulin and in non-diabetic obese persons: total lipids, triglycerides, phospholipids, alpha and beta lipoprotein cholesterol and single NEFA labeled with C 16-C 18]. Bertolini AM; Santagostino A Minerva Med; 1973 Apr; 64(28):1486-95. PubMed ID: 4706998 [No Abstract] [Full Text] [Related]
7. Effect of gemfibrozil on serum lipid levels. Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C Artery; 1980; 7(3):224-31. PubMed ID: 7008748 [TBL] [Abstract][Full Text] [Related]
8. [Long-term effects of a glycosaminoglycan on plasma lipids]. Avogaro P; Bittolo-Bon G; Alessandrini P Clin Ter; 1981 Jul; 98(1):47-61. PubMed ID: 7249572 [No Abstract] [Full Text] [Related]
9. [Changes in plasma lipids in diabetes mellitus]. Avogaro P; Capri C; Cazzolato G; Pais M Minerva Med; 1975 Oct; 66(65):3388-96. PubMed ID: 809727 [No Abstract] [Full Text] [Related]
10. [Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent]. Freyberger H; Schifferdecker E; Schatz H Med Klin (Munich); 1994 Nov; 89(11):594-7, 633. PubMed ID: 7815987 [TBL] [Abstract][Full Text] [Related]
11. Effects of short-term treatment with coenzyme A or sulodexide on plasma lipids in patients with hypertriglyceridemia (type IV) or mixed hyperlipemia (type IIb). Ghidini O; Zenari L; Guilarte N; Tessari R; Tomba A Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):390-6. PubMed ID: 3525431 [TBL] [Abstract][Full Text] [Related]
12. [Effect of phenethylbiguanide on body weight and some serum lipid indices in obese subjects, obese diabetics and obese subjects with potential diabetes]. Pompei A; Marcenaro A; Foppiani E; Jacopino GE Clin Ter; 1969 Dec; 51(6):541-60. PubMed ID: 5371379 [No Abstract] [Full Text] [Related]
13. [Effects of dimethylbiguanide (metformin) on peripheral insulin clearance and lipid biosynthesis in obese dyslipidemic subjects with and without diabetes mellitus]. Caporicci D; Mori A; Pepi R; Lapi E Clin Ter; 1979 Feb; 88(4):372-86. PubMed ID: 455913 [No Abstract] [Full Text] [Related]
14. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia. Arsenio L; Bodria P; Magnati G; Strata A; Trovato R Clin Ther; 1986; 8(5):537-45. PubMed ID: 3094958 [TBL] [Abstract][Full Text] [Related]
15. [Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias]. Goranov I; Naumova R; Kerekovska M; Balabanski L Vutr Boles; 1987; 26(1):96-101. PubMed ID: 3590738 [TBL] [Abstract][Full Text] [Related]
16. [Study of the serum lipid pattern in normal subjects, in obese subjects and in obese diabetics after oral carbohydrate stimulation]. Saitta A; Ardizzone EA; De Leo A; Cincotta M; Squadrito G Minerva Med; 1979 May; 70(22):1605-10. PubMed ID: 450300 [No Abstract] [Full Text] [Related]
17. [Behavior of serum lipids, blood coagulation factors, platelet aggregation, complement and serum immunoglobulins in a group of arteriosclerotic, hyperlipemic subjects treated with 3GS]. D'Eredità F; Avellone G; Novo S; Davì G; Abruzzese G; Di Liberti M; Pinto A; Riolo F Clin Ter; 1981 Feb; 96(3):303-24. PubMed ID: 7307448 [No Abstract] [Full Text] [Related]
18. [Effect of the administration of silymarin on serum lipid levels]. Petronelli A; Roda E; Briganti M; Morselli Labate AM; Barbara L Clin Ter; 1981 Dec; 99(5):471-82. PubMed ID: 7333068 [No Abstract] [Full Text] [Related]
19. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. II. Lipid compounds in the blood serum]. Torbus-Lisiecka B; Wesołowska T; Wira D; Chełstowski K; Bukowska H; Gregorczyk J; Pieczul-Mróz J; Olejak B Przegl Lek; 1983; 40(9):677-84. PubMed ID: 6665225 [No Abstract] [Full Text] [Related]
20. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]